Hello, everyone, and how are you this fine, sunny morning? The middle of the week has arrived, as you may know, so why not celebrate with a delicious cup of stimulation? After all, you made it this far, which is a likely sign of surviving another few days. And of course, no prescription is required, which is a good thing. And while you drink up, you can peruse some of the tidbits we have assembled to help you start the day. Hope you conquer the world and, as always, do keep in touch. …
The World Health Organization announced that a clinical trial will take place in 52 countries to study three anti-inflammatory drugs as potential treatments for Covid-19 patients, Reuters tells us. Artesunate is already used for severe malaria, imatinib for certain cancers, and infliximab for diseases of the immune system such as Crohn’s Disease and rheumatoid arthritis. So far, only corticosteroids have been proven effective against severe and critical COVID-19.
About the Author Reprints
Create a display name to comment
This name will appear with your comment
